Year |
Citation |
Score |
2019 |
Feehan AK, Zadina JE. Morphine immunomodulation prolongs inflammatory and postoperative pain while the novel analgesic ZH853 accelerates recovery and protects against latent sensitization. Journal of Neuroinflammation. 16: 100. PMID 31109346 DOI: 10.1186/S12974-019-1480-X |
0.462 |
|
2017 |
Feehan AK, Morgenweck J, Zhang X, Amgott-Kwan A, Zadina JE. Novel Endomorphin Analogs are More Potent and Longer Lasting Analgesics in Neuropathic, Postoperative, Inflammatory, and Visceral Pain Relative to Morphine. The Journal of Pain : Official Journal of the American Pain Society. PMID 28939014 DOI: 10.1016/J.Jpain.2017.08.007 |
0.462 |
|
Low-probability matches (unlikely to be authored by this person) |
2021 |
Feehan AK, Denstel KD, Katzmarzyk PT, Velasco C, Burton JH, Price-Haywood EG, Seoane L. Community versus individual risk of SARS-CoV-2 infection in two municipalities of Louisiana, USA: An assessment of Area Deprivation Index (ADI) paired with seroprevalence data over time. Plos One. 16: e0260164. PMID 34847149 DOI: 10.1371/journal.pone.0260164 |
0.105 |
|
2021 |
Zeller M, Gangavarapu K, Anderson C, Smither AR, Vanchiere JA, Rose R, Dudas G, Snyder DJ, Watts A, Matteson NL, Robles-Sikisaka R, Marshall M, Feehan AK, Sabino-Santos G, Bell-Kareem A, et al. Emergence of an early SARS-CoV-2 epidemic in the United States. Medrxiv : the Preprint Server For Health Sciences. PMID 33564781 DOI: 10.1101/2021.02.05.21251235 |
0.101 |
|
2021 |
Zeller M, Gangavarapu K, Anderson C, Smither AR, Vanchiere JA, Rose R, Snyder DJ, Dudas G, Watts A, Matteson NL, Robles-Sikisaka R, Marshall M, Feehan AK, Sabino-Santos G, Bell-Kareem AR, et al. Emergence of an early SARS-CoV-2 epidemic in the United States. Cell. PMID 34508652 DOI: 10.1016/j.cell.2021.07.030 |
0.099 |
|
2023 |
Kunz Coyne AJ, Alosaimy S, Lucas K, Lagnf AM, Morrisette T, Molina KC, DeKerlegand A, Schrack MR, Kang-Birken SL, Hobbs AL, Agee J, Perkins NB, Biagi M, Pierce M, Truong J, ... ... Feehan AK, et al. Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022. Microbiology Spectrum. e0235123. PMID 38018984 DOI: 10.1128/spectrum.02351-23 |
0.097 |
|
2022 |
Wiltz JL, Feehan AK, Molinari NM, Ladva CN, Truman BI, Hall J, Block JP, Rasmussen SA, Denson JL, Trick WE, Weiner MG, Koumans E, Gundlapalli A, Carton TW, Boehmer TK. Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021. Mmwr. Morbidity and Mortality Weekly Report. 71: 96-102. PMID 35051133 DOI: 10.15585/mmwr.mm7103e1 |
0.089 |
|
2023 |
Rose R, Nolan DJ, Ashcraft D, Feehan AK, Velez-Climent L, Huston C, Lain B, Rosenthal S, Miele L, Fogel GB, Pankey G, Garcia-Diaz J, Lamers SL. Comparing antimicrobial resistant genes and phenotypes across multiple sequencing platforms and assays for Enterobacterales clinical isolates. Bmc Microbiology. 23: 225. PMID 37596530 DOI: 10.1186/s12866-023-02975-x |
0.062 |
|
2020 |
Feehan A, Garcia-Diaz J. Bacterial, Gut Microbiome-Modifying Therapies to Defend against Multidrug Resistant Organisms. Microorganisms. 8. PMID 31991615 DOI: 10.3390/microorganisms8020166 |
0.06 |
|
2020 |
Feehan AK, Velasco C, Fort D, Burton JH, Price-Haywood EG, Katzmarzyk PT, Garcia-Diaz J, Seoane L. Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA. Emerging Infectious Diseases. 27. PMID 33171096 DOI: 10.3201/eid2701.203808 |
0.057 |
|
2020 |
Feehan AK, Fort D, Garcia-Diaz J, Price-Haywood E, Velasco C, Sapp E, Pevey D, Seoane L. Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020. Emerging Infectious Diseases. 26. PMID 32731911 DOI: 10.3201/eid2611.203029 |
0.055 |
|
2022 |
Lamers SL, Nolan DJ, LaFleur TM, Lain BN, Moot SR, Huston CR, Neilsen CD, Feehan AK, Miele L, Rose R. SARS-CoV-2 genomic surveillance as an evidence-based infection control approach in an offshore petroleum employee population. American Journal of Infection Control. PMID 35598812 DOI: 10.1016/j.ajic.2022.05.008 |
0.054 |
|
2020 |
Feehan AK, Garcia-Diaz J. Investigator Responsibilities in Clinical Research. The Ochsner Journal. 20: 44-49. PMID 32284682 DOI: 10.31486/toj.19.0085 |
0.048 |
|
2022 |
Yang L, Liang T, Pierson LM, Wang H, Fletcher JK, Wang S, Bao D, Zhang L, Huang Z, Zheng W, Zhang X, Park H, Li Y, Robinson JE, Feehan AK, et al. SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites. Research (Washington, D.C.). 2022: 9769803. PMID 35928300 DOI: 10.34133/2022/9769803 |
0.037 |
|
2021 |
Feehan AK, Fort D, Velasco C, Burton JH, Garcia-Diaz J, Price-Haywood EG, Sapp E, Pevey D, Seoane L. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 33421576 DOI: 10.1016/j.cmi.2020.12.029 |
0.037 |
|
2022 |
Miyakawa-Liu M, Feehan AK, Pai S, Garcia-Diaz J. Rates of Cognitive Decline in 100 Patients With Alzheimer Disease. The Ochsner Journal. 22: 129-133. PMID 35756598 DOI: 10.31486/toj.21.0084 |
0.035 |
|
2023 |
Lockhart J, Knapp MB, Feehan AK, Latimer S, Walter A, Craft BN, Quantz YP, Frugé H, Sylvester Terry M, Arceneaux EE, Kimball M. Implementation and Process Evaluation of Alcohol Free for 40: Community-Based Programming to Reduce Alcohol Consumption. Health Promotion Practice. 15248399221142633. PMID 36600627 DOI: 10.1177/15248399221142633 |
0.025 |
|
2023 |
Rose R, Feehan A, Lain BN, Ashcraft D, Nolan DJ, Velez-Climent L, Huston C, LaFleur T, Rosenthal S, Fogel GB, Miele L, Pankey G, Garcia-Diaz J, Lamers SL. Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates in southeast Louisiana reveals persistent genetic clusters spanning multiple locations. Journal of Infection and Public Health. 16: 1911-1917. PMID 37866269 DOI: 10.1016/j.jiph.2023.10.013 |
0.022 |
|
Hide low-probability matches. |